Role of short-acting nitroglycerin in the management of ischemic heart disease - Test2 - elhamkhani - TriplyDB

Role of short-acting nitroglycerin in the management of ischemic heart disease

Role of short-acting nitroglycerin in the management of ischemic heart disease

http://www.wikidata.org/entity/Q26796452

about

Angeli's Salt, a nitroxyl anion donor, reverses endothelin-1 mediated vascular dysfunction in murine aorta.Vasodilator Therapy: Nitrates and Nicorandil.Therapeutic Angiogenesis of Chinese Herbal Medicines in Ischemic Heart Disease: A Review.

P2860

Q38613516-D3AC255A-2178-48D8-AE58-E3A62480069A Q38867313-84A581A0-9076-4DDA-B494-5B0ADA3D87C1 Q54969538-4AE83D2A-25AF-46A6-BE76-A57E95BE3A42

P2860

Role of short-acting nitroglycerin in the management of ischemic heart disease

http://www.wikidata.org/entity/Q26796452

description

2015 nî lūn-bûn

@nan

2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Role of short-acting nitroglycerin in the management of ischemic heart disease

@ast

Role of short-acting nitroglycerin in the management of ischemic heart disease

@en

Role of short-acting nitroglycerin in the management of ischemic heart disease

@nl

type

label

Role of short-acting nitroglycerin in the management of ischemic heart disease

@ast

Role of short-acting nitroglycerin in the management of ischemic heart disease

@en

Role of short-acting nitroglycerin in the management of ischemic heart disease

@nl

prefLabel

Role of short-acting nitroglycerin in the management of ischemic heart disease

@ast

Role of short-acting nitroglycerin in the management of ischemic heart disease

@en

Role of short-acting nitroglycerin in the management of ischemic heart disease

@nl

P1433

Q26796452-8FBC0199-58F4-4C0F-B31A-E48BEB22AF3A

P1476

Q26796452-624416A7-2069-47BE-8E1C-B999621C983C

P2093

Q26796452-268BA35C-7D0F-496D-9429-98FCC7564A6B

Q26796452-4478BED4-EED9-4230-B654-B0977AAF2DD2

Q26796452-5571F702-3760-49C1-82EE-F142EC5E5169

Q26796452-82276E5A-2D91-4DE0-85F4-905AE3D53EA3

P275

Q26796452-5BDE457F-F924-46C4-9E95-D5DD3B4AEDB9

P2860

Q26796452-09A6DA7F-C4E7-4183-8D29-2D5278480FC6

Q26796452-0D6719DC-6908-4E4D-8CB6-14C51EB1DD0A

Q26796452-13DED699-8590-40B1-9A09-56F710EB5247

Q26796452-228B7D7E-C09D-4215-9669-0C3687AA4EA6

Q26796452-23BB53FC-021D-4E42-B9C0-0F23E0F01DCE

Q26796452-29353932-4179-4AED-9EE5-431E0769E733

Q26796452-38150C82-5BE2-4EEE-B9C9-0BBA1E6810C8

Q26796452-3CAB97A1-6ABF-47B0-A471-E8ED855E1917

Q26796452-3F875D66-7975-4DC9-B0E8-C61D04891C6A

Q26796452-42DA955A-7088-469F-8B57-49A4244E3022

P304

Q26796452-717EC7C1-17F5-40F8-A0BA-7F6FEF54C492

P31

Q26796452-3C7B0177-C776-408E-9513-A95C7ABE5972

Q26796452-57841A32-01C2-4CB4-905A-A39DA7AA16CD

P356

Q26796452-9B528512-889B-4C15-8F39-CC6F007A96CE

P407

Q26796452-2ABCE5A1-CE88-4B83-9006-8E6C5F00B523

P478

Q26796452-F10C1BCD-F7DB-42D8-80DC-FDD8E20943C8

P50

Q26796452-766120A0-CAEF-422A-ABCE-DE86DFBDCCEE

P5008

Q26796452-5F5DE874-1D76-42D3-A553-25F236A7D7DD

P577

Q26796452-36D1FC16-33F7-404A-BB6B-C155C96036BB

P5875

Q26796452-31922B23-3FF0-446F-B733-5A766642D2F1

P698

Q26796452-47F8E10E-084E-4EB7-A0CD-16CF8DCE1324

P921

Q26796452-5039BE91-F8F2-4DFA-A0A6-E5B786D0C120

Q26796452-D83941C7-BAA8-4C16-8384-E14605FF5B8A

Q26796452-FACB483C-D4E0-4BAC-B93D-E5FA8F0BE503

Q26796452-a612e222-4a47-0357-2f52-ed5bbce5d2b4

Q26796452-b5671f1e-4b42-2fb4-fb49-982336e2ceae

Q26796452-b5a2e034-47ae-3623-f5f2-523426ec3523

Q26796452-dd32d1f1-4bfb-2370-b598-d3d00c51e543

P932

Q26796452-BD92119F-7A8E-41D6-A1DD-99AEB5B0B37A

P356

P1433

Drug Design, Development and Therapy

P1476

Role of short-acting nitroglycerin in the management of ischemic heart disease

@en

P2093

Ivo R Buschmann

http://www.w3.org/2001/XMLSchema#string

Katherine P Cabral

http://www.w3.org/2001/XMLSchema#string

Mandeep S Sidhu

http://www.w3.org/2001/XMLSchema#string

Santosh K Padala

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association

Design and rationale of the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial Veterans Affairs Cooperative Studies Program no. 424

Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology.

2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, a

Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations

Nitric oxide supersensitivity: a possible molecular mechanism of migraine pain.

Endogenous and exogenous nitrates and their role in myocardial ischaemia.

A large scale comparative study in general practice with nitroglycerin spray and tablet formulations in elderly patients with angina pectoris.

Optimal medical therapy with or without PCI for stable coronary disease.

Effects of nitroglycerin on regional myocardial blood flow in coronary artery disease.

P304

4793-805

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DDDT.S79116

http://www.w3.org/2001/XMLSchema#string

P407

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

William E Boden

P5008

P577

2015-08-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281553331

http://www.w3.org/2001/XMLSchema#string

P698

26316714

http://www.w3.org/2001/XMLSchema#string

P921

vasodilator agent

coronary circulation

myocardial ischemia

P932

4548722

http://www.w3.org/2001/XMLSchema#string